Qsemble Capital Management LP Has $607,000 Stock Position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Qsemble Capital Management LP lifted its position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 74.9% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 67,775 shares of the pharmacy operator’s stock after acquiring an additional 29,025 shares during the period. Qsemble Capital Management LP’s holdings in Walgreens Boots Alliance were worth $607,000 as of its most recent SEC filing.

Other large investors have also made changes to their positions in the company. Inlet Private Wealth LLC grew its position in Walgreens Boots Alliance by 1.9% during the second quarter. Inlet Private Wealth LLC now owns 47,820 shares of the pharmacy operator’s stock valued at $578,000 after purchasing an additional 900 shares in the last quarter. Capital Investment Counsel Inc grew its stake in shares of Walgreens Boots Alliance by 6.6% in the 2nd quarter. Capital Investment Counsel Inc now owns 15,340 shares of the pharmacy operator’s stock valued at $186,000 after buying an additional 950 shares in the last quarter. Continuum Advisory LLC increased its holdings in Walgreens Boots Alliance by 71.2% in the second quarter. Continuum Advisory LLC now owns 2,453 shares of the pharmacy operator’s stock worth $30,000 after buying an additional 1,020 shares during the last quarter. Sumitomo Mitsui DS Asset Management Company Ltd lifted its stake in Walgreens Boots Alliance by 1.6% in the second quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 65,690 shares of the pharmacy operator’s stock valued at $795,000 after acquiring an additional 1,038 shares during the last quarter. Finally, Sequoia Financial Advisors LLC grew its position in Walgreens Boots Alliance by 4.4% in the third quarter. Sequoia Financial Advisors LLC now owns 25,215 shares of the pharmacy operator’s stock worth $226,000 after acquiring an additional 1,063 shares in the last quarter. Institutional investors and hedge funds own 58.59% of the company’s stock.

Walgreens Boots Alliance Trading Down 3.6 %

Shares of NASDAQ:WBA opened at $8.73 on Wednesday. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.68 and a quick ratio of 0.37. Walgreens Boots Alliance, Inc. has a 1-year low of $8.08 and a 1-year high of $27.05. The business’s 50 day moving average is $9.13 and its 200-day moving average is $11.39.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings results on Tuesday, October 15th. The pharmacy operator reported $0.39 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.36 by $0.03. The firm had revenue of $37.50 billion for the quarter, compared to analyst estimates of $35.75 billion. Walgreens Boots Alliance had a negative net margin of 5.85% and a positive return on equity of 14.23%. The business’s revenue for the quarter was up 5.9% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.67 EPS. As a group, sell-side analysts expect that Walgreens Boots Alliance, Inc. will post 1.53 EPS for the current fiscal year.

Walgreens Boots Alliance Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, December 12th. Shareholders of record on Monday, November 18th will be issued a dividend of $0.25 per share. This represents a $1.00 dividend on an annualized basis and a yield of 11.45%. The ex-dividend date of this dividend is Monday, November 18th. Walgreens Boots Alliance’s payout ratio is -9.99%.

Analysts Set New Price Targets

Several equities research analysts recently issued reports on WBA shares. Jefferies Financial Group reduced their price objective on shares of Walgreens Boots Alliance from $19.00 to $9.00 and set a “hold” rating for the company in a research note on Wednesday, October 23rd. Bank of America decreased their target price on Walgreens Boots Alliance from $11.00 to $7.50 and set an “underperform” rating for the company in a research report on Wednesday, September 4th. Morgan Stanley reduced their price objective on shares of Walgreens Boots Alliance from $9.00 to $7.00 and set an “underweight” rating for the company in a research note on Friday, October 11th. UBS Group upped their price target on shares of Walgreens Boots Alliance from $9.00 to $10.00 and gave the company a “neutral” rating in a report on Thursday, October 17th. Finally, Truist Financial dropped their price objective on Walgreens Boots Alliance from $13.00 to $10.00 and set a “hold” rating on the stock in a research note on Monday, October 7th. Four analysts have rated the stock with a sell rating, nine have assigned a hold rating and two have issued a buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $12.88.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.